Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion

PURPOSE: The purpose of this study was to determine the long-term outcomes of intravitreal bevacizumab (IVB) or intravitreal tissue plasminogen activator (tPA) or vitrectomy for macular edema associated with a branch retinal vein occlusion (BRVO). METHODS: This was a retrospective, interventional ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagai, Kazuyuki, Ogino, Nobuchika, Fukami, Marie, Furukawa, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469473/
https://www.ncbi.nlm.nih.gov/pubmed/31043767
http://dx.doi.org/10.2147/OPTH.S195600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469473/
https://www.ncbi.nlm.nih.gov/pubmed/31043767
http://dx.doi.org/10.2147/OPTH.S195600

Ejemplares similares